Comelli F - Search Results

1

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. Costa B, et al. Among authors: comelli f. Eur J Pharmacol. 2007 Feb 5;556(1-3):75-83. doi: 10.1016/j.ejphar.2006.11.006. Epub 2006 Nov 10. Eur J Pharmacol. 2007. PMID: 17157290

2

Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature.

Luongo L, Costa B, D'Agostino B, Guida F, Comelli F, Gatta L, Matteis M, Sullo N, De Petrocellis L, de Novellis V, Maione S, Di Marzo V. Luongo L, et al. Among authors: comelli f. Pharmacol Res. 2012 Sep;66(3):243-50. doi: 10.1016/j.phrs.2012.05.005. Epub 2012 May 24. Pharmacol Res. 2012. PMID: 22634607

3

The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.

Bolognini D, Costa B, Maione S, Comelli F, Marini P, Di Marzo V, Parolaro D, Ross RA, Gauson LA, Cascio MG, Pertwee RG. Bolognini D, et al. Among authors: comelli f. Br J Pharmacol. 2010 Jun;160(3):677-87. doi: 10.1111/j.1476-5381.2010.00756.x. Br J Pharmacol. 2010. PMID: 20590571 Free PMC article.

4

Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.

Bettoni I, Comelli F, Colombo A, Bonfanti P, Costa B. Bettoni I, et al. Among authors: comelli f. CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):34-44. doi: 10.2174/1871527311312010008. CNS Neurol Disord Drug Targets. 2013. PMID: 23394519

5

Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.

Comelli F, Bettoni I, Colleoni M, Giagnoni G, Costa B. Comelli F, et al. Phytother Res. 2009 Dec;23(12):1678-84. doi: 10.1002/ptr.2806. Phytother Res. 2009. PMID: 19441010

6

Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice.

Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B. Bettoni I, et al. Among authors: comelli f. Glia. 2008 Sep;56(12):1312-9. doi: 10.1002/glia.20699. Glia. 2008. PMID: 18615568

7

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.

Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B. Comelli F, et al. Phytother Res. 2008 Aug;22(8):1017-24. doi: 10.1002/ptr.2401. Phytother Res. 2008. PMID: 18618522

8

Palmitoylethanolamide relieves pain and preserves pancreatic islet cells in a murine model of diabetes.

Donvito G, Bettoni I, Comelli F, Colombo A, Costa B. Donvito G, et al. Among authors: comelli f. CNS Neurol Disord Drug Targets. 2015;14(4):452-62. doi: 10.2174/1871527314666150429111537. CNS Neurol Disord Drug Targets. 2015. PMID: 25921749

9

Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.

Comelli F, Bettoni I, Colombo A, Fumagalli P, Giagnoni G, Costa B. Comelli F, et al. Eur J Pharmacol. 2010 Jul 10;637(1-3):62-9. doi: 10.1016/j.ejphar.2010.03.061. Epub 2010 Apr 14. Eur J Pharmacol. 2010. PMID: 20399204

10

The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.

Costa B, Bettoni I, Petrosino S, Comelli F, Giagnoni G, Di Marzo V. Costa B, et al. Among authors: comelli f. Pharmacol Res. 2010 Jun;61(6):537-46. doi: 10.1016/j.phrs.2010.02.001. Epub 2010 Feb 6. Pharmacol Res. 2010. PMID: 20138997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results